Growth Metrics

Arcadia Biosciences (RKDA) Change in Account Payables (2016 - 2025)

Arcadia Biosciences' Change in Account Payables history spans 12 years, with the latest figure at -$30000.0 for Q2 2025.

  • For Q2 2025, Change in Account Payables fell 700.0% year-over-year to -$30000.0; the TTM value through Dec 2025 reached -$30000.0, down 3.45%, while the annual FY2025 figure was -$30000.0, 3.45% down from the prior year.
  • Change in Account Payables reached -$30000.0 in Q2 2025 per RKDA's latest filing, up from -$51000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $18000.0 in Q3 2021 to a low of -$54000.0 in Q1 2021.
  • Average Change in Account Payables over 5 years is -$5062.5, with a median of $6000.0 recorded in 2021.
  • The largest YoY upside for Change in Account Payables was 1100.0% in 2023 against a maximum downside of 760.0% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $13000.0 in 2021, then crashed by 92.31% to $1000.0 in 2022, then surged by 1100.0% to $12000.0 in 2023, then plummeted by 525.0% to -$51000.0 in 2024, then surged by 41.18% to -$30000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Change in Account Payables are -$30000.0 (Q2 2025), -$51000.0 (Q3 2024), and $5000.0 (Q2 2024).